<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wang TQ</submitter><funding>Wenzhou Medical University</funding><pagination>9058135</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7424524</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>2020</volume><pubmed_abstract>Qingxin kaiqiao fang (QKF), a traditional Chinese medicine compound, has been applied to treat Alzheimer's disease (AD) for many years and has exhibited remarkable effects. However, the underlying mechanism is still not explicit. The current study aims to investigate whether QKF exerts an antiapoptotic role through the p38 MAPK pathway in the course of AD. Network pharmacology analysis was applied to study the effective components, possible therapeutic targets, and AD-related pathway of QKF. Further, the AD cell model was established using amyloid-beta (A&lt;i>β&lt;/i>)&lt;sub>25-35&lt;/sub> peptide and primary hippocampal neuronal cells extracted from newborn Sprague-Dawley rats. Microtubule-associated protein-2 (MAP-2) imaging was used to detect the morphology of hippocampal neurons. Western blot (W</pubmed_abstract><journal>Evidence-based complementary and alternative medicine : eCAM</journal><pubmed_title>Qingxin Kaiqiao Fang Inhibits A&lt;i>β&lt;/i> &lt;sub>25-35&lt;/sub>-Induced Apoptosis in Primary Cultured Rat Hippocampal Neuronal Cells via the p38 MAPK Pathway: An Experimental Validation and Network Pharmacology Study.</pubmed_title><pmcid>PMC7424524</pmcid><funding_grant_id>LY15H270016</funding_grant_id><funding_grant_id>81573896</funding_grant_id><pubmed_authors>Gao SY</pubmed_authors><pubmed_authors>Xu LT</pubmed_authors><pubmed_authors>Lin JW</pubmed_authors><pubmed_authors>Hu HY</pubmed_authors><pubmed_authors>Wang TQ</pubmed_authors><pubmed_authors>Lai XX</pubmed_authors><pubmed_authors>Shen Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Qingxin Kaiqiao Fang Inhibits A&lt;i>β&lt;/i> &lt;sub>25-35&lt;/sub>-Induced Apoptosis in Primary Cultured Rat Hippocampal Neuronal Cells via the p38 MAPK Pathway: An Experimental Validation and Network Pharmacology Study.</name><description>Qingxin kaiqiao fang (QKF), a traditional Chinese medicine compound, has been applied to treat Alzheimer's disease (AD) for many years and has exhibited remarkable effects. However, the underlying mechanism is still not explicit. The current study aims to investigate whether QKF exerts an antiapoptotic role through the p38 MAPK pathway in the course of AD. Network pharmacology analysis was applied to study the effective components, possible therapeutic targets, and AD-related pathway of QKF. Further, the AD cell model was established using amyloid-beta (A&lt;i>β&lt;/i>)&lt;sub>25-35&lt;/sub> peptide and primary hippocampal neuronal cells extracted from newborn Sprague-Dawley rats. Microtubule-associated protein-2 (MAP-2) imaging was used to detect the morphology of hippocampal neurons. Western blot (W</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020</publication><modification>2025-04-18T19:29:16.126Z</modification><creation>2020-08-29T07:22:45Z</creation></dates><accession>S-EPMC7424524</accession><cross_references><pubmed>32831882</pubmed><doi>10.1155/2020/9058135</doi></cross_references></HashMap>